Featured Article

Nephroprotective Properties of the Glucose Dependent Insulinotropic | the ultimate collection

Heather Aug 05, 2026

Nephroprotective Properties of the Glucose

Nephroprotective Properties of the Glucose Dependent Insulinotropic
Nephroprotective Properties of the Glucose Dependent Insulinotropic

The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Additional to the pancreas, receptors for GLP-1 are widely distributed in various organs, causing positive effects on endothelial function and vascular atherogenesis.

Figure 1 from Effect on Hemoglobin A1c HbA1c and Body Weight After
Figure 1 from Effect on Hemoglobin A1c HbA1c and Body Weight After

Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1), also known as incretins, are hormones released in the intestine in response to the intake of nutrients, and ...

Nephroprotective Properties of the Glucose

Glucose dependent insulinotropic peptide
Glucose dependent insulinotropic peptide

Diabetes mellitus is the leading cause of chronic kidney disease, and about 30-40% of patients with diabetes will develop kidney disease. Incretin hormones have received attention during the past three decades not only as a pharmacotherapy for the treatment of type 2 diabetes, but also for their cardiorenometabolic effects. The main incretins are glucagon-like peptide-1 (GLP-1) and glucose ...

The nephroprotective properties of dual GIP and GLP-1 receptor agonists as a new drug to treat type 2 diabetes are presented and preliminary results suggest that tirzepatide improves kidney outcomes in adults with type 1 diabetes with increased cardiovascular risk. Diabetes mellitus is the leading cause of chronic kidney disease, and about 30-40% of patients with diabetes will develop kidney ...

PDF Glucose Dependent Insulinotropic Polypeptide Receptor Expressing
PDF Glucose Dependent Insulinotropic Polypeptide Receptor Expressing

Nephroprotective Properties of the Glucose

Journal Article Summary The article examines the nephroprotective effects of two incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), particularly focusing on their combined use as receptor agonists in treating type 2 diabetes mellitus (T2DM). This topic is significant because diabetes is a leading cause of chronic kidney disease, with a ...

The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) [3]. In patients with type 2 diabetes (T2DM), the incretin effect is diminished or completely lost [4].

Effect on Hemoglobin A1c HbA1c and Body Weight After Discontinuation
Effect on Hemoglobin A1c HbA1c and Body Weight After Discontinuation

Overview of Nephroprotective Properties Of The Glucose Dependent Insulinotropic

Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists. Biomedicines, 10 (10), 2586. https://doi.org/10.3390/biomedicines10102586

Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Tomislav Bulum 1,2 Citation: Bulum, T. roprotective Properties of the Glucose-Dependent Insulinotropic Polypepti Academic Editor: Isha Sharma

Glucagon like Peptide 1 Glucose Dependent Insulinotropic Polypeptide
Glucagon like Peptide 1 Glucose Dependent Insulinotropic Polypeptide
PDF Glucose dependent Insulinotropic Polypeptide and Glucagon like
PDF Glucose dependent Insulinotropic Polypeptide and Glucagon like
The mechanisms of dual incretin receptor agonists Glucagon like
The mechanisms of dual incretin receptor agonists Glucagon like
Mechanism of glucose dependent insulinotropic polypeptide GIP
Mechanism of glucose dependent insulinotropic polypeptide GIP
Schematic Depiction of the Pleiotropic Benefits of Dual
Schematic Depiction of the Pleiotropic Benefits of Dual